Clinical Trials Directory

Trials / Completed

CompletedNCT05309837

Effect of Polydextrose on Fecal Bulk and Bowel Function in Mildly Constipated Subjects

A Two-center, Randomized, Double-blind, Placebo Controlled, Parallel Study to Evaluate the Effect of Polydextrose on Fecal Bulk and Bowel Function in Mildly Constipated Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Tate & Lyle · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Polydextrose (PDX) (8-30g/day) has been reported to increase faecal bulk and consistency, leading to easier stool passage in healthy subjects. Studies on its effect on defaecation frequency and colonic transit time have provided mixed results. The primary objective was to investigate the effect of PDX consumption by mildly constipated subjects on faecal bulk, measured as total faecal wet weight of 4-day collections. Secondary outcomes (faecal dry weight, defaecation frequency, stool consistency, ease of stool passage, total colonic transit time and gastrointestinal symptoms) were also explored. 51 subjects participated in a 4-week, two-center, randomized, double-blind, placebo-controlled, parallel study testing a control (CON) and a PDX treatment (18 g/d included in biscuits and drink mixtures)

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPolydextrosePolydextrose-enriched food products
DIETARY_SUPPLEMENTplacebo-controlledControl food products

Timeline

Start date
2012-11-01
Primary completion
2013-05-01
Completion
2013-09-19
First posted
2022-04-04
Last updated
2022-04-04

Source: ClinicalTrials.gov record NCT05309837. Inclusion in this directory is not an endorsement.